RÉSUMÉ DIGEST
ACT 201 (SB 14) 2023 Regular Session Bernard
Existing law provides for the designation of controlled dangerous substances into Schedules
I, II, III, IV, and V based upon the potential for addiction and abuse of the substances.
New law adds Zipeprol, Amineptine, Mesocarb, and Methiopropamine to Schedule I.
New law adds Daridorexant to Schedule IV and removes Fenfluramine.
New law adds Ganaxolone to Schedule V.
New law updates the structural language for stimulants and synthetic cannabinoids in
Schedule I.
Prior law prohibited an individual from knowingly or intentionally producing,
manufacturing, distributing, or possessing with intent to produce, manufacture, or distribute
a material, compound, mixture, or preparation intended for human consumption which
contains a hallucinogenic plant. Further provides a list of prohibited hallucinogenic plants.
New law adds amanita pantherina to the list of prohibited hallucinogenic plants.
Effective August 1, 2023.
(Amends R.S. 40:964(Schedule I)(E)(1)(i) and (iii) and (8) and (F)(1)-(8), (12), (17)-(22),
and (24)-(29) and (Schedule V)(D)(6); adds R.S. 40:964(Schedule I)(A)(100) and (E)(14)-
(16), (Schedule IV)(B)(58), and (Schedule V)(D)(7) and 989.1(C)(2)(nn); repeals R.S.
40:964(Schedule IV)(C))


Statutes affected:
SB14 Original: 40:964(S
SB14 Engrossed: 40:964(S
SB14 Enrolled: 40:964(S
SB14 Act : 40:964(S